Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

Gilead analysis shows remdesivir reduced coronavirus death risk, more studies neededRemdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered medicine helped shorten hospital recovery times, according to data in April from a separate U.S. government trial. In the latest analysis, Gilead said it analyzed data from 312 patients treated in its late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity. Gilead's late-stage study evaluated the safety and efficacy of five-day and 10-day dosing durations of remdesivir in hospitalized patients.




from Yahoo News - Latest News & Headlines https://ift.tt/2CrabuA
via Latest News

Comments

Post a Comment

Popular posts from this blog

Facebook's latest bug exposed the private photos of 6.8 million users - The INQUIRER

Facebook's latest bug exposed the private photos of 6.8 million users    The INQUIRER After a year from hell, Facebook parties like it's 2017    The Guardian Facebook bug may have exposed users’ photos    ConsumerAffairs Bug may have exposed photos from 7 million Facebook users | WSB-TV    WSB Atlanta Use This Tool To See If Your Photos Were Exposed In Facebook's Latest Privacy Blunder    Hot Hardware View full coverage on Google News from Technology - Latest - Google News https://ift.tt/2Bs7iVW via Technology
Read more